Nasdaq

In the first six months of the year, Nasdaq welcomed 69 IPOs, raising $17.4 billion, outpacing the New York Stock Exchange.

Among the most striking business developments to emerge from the coronavirus pandemic is the way it has redefined the relationship between companies and their customers.

Much about the market’s performance during the coronavirus pandemic, both on the way down and on the way back up again, makes little or no sense.

Daily energy market commentary provided by Nasdaq Corporate Solutions Advisory Services' Energy Team.

As the U.S. is seeing daily new cases of the coronavirus rise above 50,000 for the first time, making reopening plans even more uncertain, investors will be looking for signs that the economy is finding its footing

It’s not hyperbole to describe Zoom Video’s (ZM) first quarter earnings results and its strong fiscal year guidance as simply breathtaking.

Investing in international markets is a multi-dimensional effort aided by having a rather unique perspective, especially during a global health pandemic and economic crisis.

Following the fastest decline from record highs in Q1, equities roared back with a vengeance in Q2.

Following the fastest decline from record highs in Q1, equities roared back with a vengeance in Q2.

I think we can all agree that diversification of equity holdings is key to the success of investment portfolios.

Wow, what a quarter! Q2 2020 has seen the biggest single-quarter gains in the stock market for decades. That in itself is remarkable, but when you consider the conditions under which that has occurred, it is stunning.

TKTK

The Nasdaq Q-50 Index: The Next Generation of Innovators

Daily energy market commentary provided by Nasdaq Corporate Solutions Advisory Services' Energy Team.

Magnus Haglind, Senior Vice President of Market Technology at Nasdaq, shares how the Marketplace Services Platform can help markets move to the next phase of digitalization.

Today we kick off what is typically the weakest quarter of the year after a blockbuster second quarter, but there is nothing typical about this quarter.

The stock market might have traded in a tight range since early June, but that was still enough to produce its best quarterly performance in more than three decades.

The COVID-19 pandemic has been a catalyst for dynamic change for advisor businesses in all but one area – the ongoing and inexorable march of regulation and compliance.

The coronavirus pandemic is having a profound impact on the healthcare sector in 2020, effects that are clearly benefiting select biotechnology exchange traded funds.

Topics Include: adding perspective to the recent pullback in domestic equity markets with various indicators, discussing the continued presence of fixed income, and highlighting the continued strength in the precious metals space